Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Vascudyne Inc. currently has 1 pending office action in its patent portfolio, which is situated in the Medical Devices & Mechanical Engineering technology area. This action is assigned to 1 distinct examiner. The portfolio's active prosecution is contained within 1 distinct art unit, indicating a targeted approach to its medical and mechanical innovations. The presence of 1 distinct art unit within the Medical Devices & Mechanical Engineering field suggests that the pending application falls into a specific technical niche.
LE, KHOA TAN is the busiest examiner for Vascudyne Inc., with 1 pending office action currently under review. This single action accounts for the total pending workload for the company. As a result, the company's immediate prosecution efforts are entirely focused on the requirements and feedback provided by LE, KHOA TAN. For practitioners, this means that all current strategic responses and examiner interviews are concentrated with one specific official. This concentration allows for a highly tailored approach to prosecution, as the applicant can focus exclusively on the preferences and historical tendencies of this single examiner.
The 1 to 1 ratio of pending actions to examiners provides a streamlined prosecution path without the complexities of multi-examiner coordination. This data suggests a stable and manageable prosecution workload for the company's current intellectual property assets. Practitioners should focus on the examiner's specific patterns, as the 1 to 1 ratio of pending actions to examiners means there are no other active examiners to compare against. This concentration provides a clear path for direct communication and negotiation during the prosecution phase.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LE, KHOA TAN | 1 | 78.0% | +38.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18845665 | Nerve Wrap Using Constructed Tissue | LE, KHOA TAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18845665 | Nerve Wrap Using Constructed Tissue | LE, KHOA TAN | — |
| Art Unit | Apps |
|---|---|
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18845665 | Nerve Wrap Using Constructed Tissue | LE, KHOA TAN | 3771 | §102§103 | Final Rejection | — | Pending | Sep 10, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial